Natco Pharma (India) Investor Sentiment

NATCOPHARM   1,376  38.05  2.84%   
Under 55% of Natco Pharma's traders are presently thinking to get in. The analysis of overall sentiment of trading Natco Pharma Limited stock suggests that some investors are interested at this time. Natco Pharma's investing sentiment shows overall attitude of investors towards Natco Pharma Limited.
  
over a week ago at news.google.com         
NATCO Pharma Limited Passed Our Checks, And Its About To Pay A 1.50 Dividend - Simply Wall St
Google News at Macroaxis
over a week ago at news.google.com         
NATCO Pharma Limited Approves to Declare Second Interim Dividend for the Financial Year 2024-2025, P...
Google News at Macroaxis
over a week ago at news.google.com         
NATCO Pharma Has Announced A Dividend Of 1.50 - Simply Wall St
Google News at Macroaxis
over two weeks ago at news.google.com         
Earnings Beat NATCO Pharma Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Thei...
Google News at Macroaxis
over two weeks ago at news.google.com         
NATCO Pharma to Seek Acquisition - Marketscreener.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Natco Pharma Q2 Results Net profit shoots up 83 percent to Rs 676 crore - The Economic Times
Google News at Macroaxis
over a month ago at news.google.com         
Natco Pharma Ltd. Stock Sees Dip, But Long-Term Outlook Remains Positive - MarketsMojo
Google News at Macroaxis
over a month ago at news.google.com         
Heres why Natco Pharma share price gained over 4 percent on October 7 details - Business Standard
Google News at Macroaxis
over two months ago at news.google.com         
Natco Pharma Ltd slips for fifth straight session - Business Standard
Google News at Macroaxis
over two months ago at news.google.com         
Trade Spotlight How should you trade Bajaj Finance, Nestle, Indian Hotels, Natco Pharma, Havells and...
Google News at Macroaxis
over two months ago at news.google.com         
Natco Pharma stock rises 3 percent after subsidiary invests 8 mn in biotech firm - Business Standard
Google News at Macroaxis
over two months ago at news.google.com         
NATCO Pharmas Canadian arm invests 8M in Xenotransplantation pioneer - BusinessLine
Google News at Macroaxis
over two months ago at news.google.com         
In spite of recent selling, insiders still control 30 percent of NATCO Pharma Limited - Simply Wall ...
Google News at Macroaxis
over three months ago at news.google.com         
Natco Pharma rises 4 percent after filing ANDA for generic lung cancer drug - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Natco Pharma Consolidated June 2024 Net Sales at Rs 1,362.60 crore, up 19.47 percent Y-o-Y - Moneyco...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Natco Pharma that are available to investors today. That information is available publicly through Natco media outlets and privately through word of mouth or via Natco internal channels. However, regardless of the origin, that massive amount of Natco data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Natco Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Natco Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Natco Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Natco Pharma alpha.

Natco Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Trade Spotlight How should you trade Bajaj Finance, Nestle, Indian Hotels, Natco Pharma, Havells and... - Moneycontrol
09/18/2024
2
Natco Pharma Ltd. Stock Sees Dip, But Long-Term Outlook Remains Positive - MarketsMojo
10/25/2024
3
Earnings Beat NATCO Pharma Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Simply Wall St
11/14/2024
4
NATCO Pharma Limited Passed Our Checks, And Its About To Pay A 1.50 Dividend - Simply Wall St
11/22/2024

Complementary Tools for Natco Stock analysis

When running Natco Pharma's price analysis, check to measure Natco Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natco Pharma is operating at the current time. Most of Natco Pharma's value examination focuses on studying past and present price action to predict the probability of Natco Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natco Pharma's price. Additionally, you may evaluate how the addition of Natco Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements